Insmed

NASDAQ: INSM · Real-Time Price · USD
126.78
-0.97 (-0.76%)
At close: Aug 15, 2025, 12:14 PM

Insmed Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-913.77M -749.57M -481.53M -434.65M
Depreciation & Amortization
11.01M 10.58M 10.33M 14.18M
Stock-Based Compensation
96.83M 74.78M 57.69M 46.02M
Other Working Capital
26.8M -28.8M -35.3M -25.43M
Other Non-Cash Items
125.22M 167.18M 6.5M 52.04M
Deferred Income Tax
n/a n/a n/a 17.69M
Change in Working Capital
-3.18M -39.22M 6.58M -58.58M
Operating Cash Flow
-683.88M -536.25M -400.44M -363.3M
Capital Expenditures
-21.92M -13.29M -9.88M -7.29M
Cash Acquisitions
n/a n/a 24.71M -6.7M
Purchase of Investments
-1.58B -588.73M -99.71M -50.29M
Sales Maturities Of Investments
1.02B 375M 75M 57M
Other Investing Acitivies
n/a 3.42M -24.71M -57M
Investing Cash Flow
-583.17M -223.6M -34.58M -64.28M
Debt Repayment
147.39M -1.22M 349.4M 336.34M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
109.51M 17.18M 151.72M 6.32M
Financial Cash Flow
1.34B 168.44M 793.27M 612.55M
Net Cash Flow
72.66M -591.66M 357.25M 184.03M
Free Cash Flow
-705.8M -549.53M -410.32M -370.59M